CN107853703A - A kind of preparation method for being used to alleviate the preparation of physical fatigue - Google Patents
A kind of preparation method for being used to alleviate the preparation of physical fatigue Download PDFInfo
- Publication number
- CN107853703A CN107853703A CN201711114016.5A CN201711114016A CN107853703A CN 107853703 A CN107853703 A CN 107853703A CN 201711114016 A CN201711114016 A CN 201711114016A CN 107853703 A CN107853703 A CN 107853703A
- Authority
- CN
- China
- Prior art keywords
- preparation
- group
- alleviate
- physical fatigue
- extract solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 68
- 239000002245 particle Substances 0.000 claims abstract description 97
- 239000000047 product Substances 0.000 claims abstract description 91
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 66
- 238000000034 method Methods 0.000 claims abstract description 43
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 34
- 235000011034 Rubus glaucus Nutrition 0.000 claims abstract description 26
- 244000235659 Rubus idaeus Species 0.000 claims abstract description 26
- 235000009122 Rubus idaeus Nutrition 0.000 claims abstract description 26
- 239000000284 extract Substances 0.000 claims abstract description 25
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 23
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 23
- 239000000843 powder Substances 0.000 claims abstract description 22
- 239000006228 supernatant Substances 0.000 claims abstract description 14
- 239000000419 plant extract Substances 0.000 claims abstract description 11
- 239000000706 filtrate Substances 0.000 claims abstract description 6
- 238000007789 sealing Methods 0.000 claims abstract description 6
- 238000003756 stirring Methods 0.000 claims abstract description 6
- 239000006071 cream Substances 0.000 claims abstract description 5
- 238000001914 filtration Methods 0.000 claims abstract description 5
- 230000002829 reductive effect Effects 0.000 claims abstract description 5
- 238000003809 water extraction Methods 0.000 claims abstract description 5
- 238000001556 precipitation Methods 0.000 claims abstract description 4
- 240000008866 Ziziphus nummularia Species 0.000 claims abstract 3
- 239000003814 drug Substances 0.000 claims description 41
- 239000002994 raw material Substances 0.000 claims description 23
- 239000000203 mixture Substances 0.000 claims description 21
- 229940079593 drug Drugs 0.000 claims description 17
- 239000000654 additive Substances 0.000 claims description 11
- 230000001954 sterilising effect Effects 0.000 claims description 11
- 235000013305 food Nutrition 0.000 claims description 9
- 235000020985 whole grains Nutrition 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 239000000945 filler Substances 0.000 claims description 5
- 239000003755 preservative agent Substances 0.000 claims description 5
- 230000002335 preservative effect Effects 0.000 claims description 5
- 235000018102 proteins Nutrition 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 4
- 235000015872 dietary supplement Nutrition 0.000 claims description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 4
- 239000011707 mineral Substances 0.000 claims description 4
- 238000012856 packing Methods 0.000 claims description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 4
- 239000011122 softwood Substances 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 4
- 230000033228 biological regulation Effects 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 2
- 102000008186 Collagen Human genes 0.000 claims description 2
- 108010035532 Collagen Proteins 0.000 claims description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 2
- 108010084695 Pea Proteins Proteins 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- 229930003451 Vitamin B1 Natural products 0.000 claims description 2
- 229930003268 Vitamin C Natural products 0.000 claims description 2
- 229930003316 Vitamin D Natural products 0.000 claims description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 2
- 229930003427 Vitamin E Natural products 0.000 claims description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 2
- 235000013734 beta-carotene Nutrition 0.000 claims description 2
- 239000011648 beta-carotene Substances 0.000 claims description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 2
- 229960002747 betacarotene Drugs 0.000 claims description 2
- 239000011575 calcium Substances 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 claims description 2
- 229910052804 chromium Inorganic materials 0.000 claims description 2
- 239000011651 chromium Substances 0.000 claims description 2
- 229920001436 collagen Polymers 0.000 claims description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 2
- 235000011868 grain product Nutrition 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- 239000011777 magnesium Substances 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- 229910052748 manganese Inorganic materials 0.000 claims description 2
- 239000011572 manganese Substances 0.000 claims description 2
- 235000013557 nattō Nutrition 0.000 claims description 2
- 235000019702 pea protein Nutrition 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 2
- 239000011669 selenium Substances 0.000 claims description 2
- 229910052711 selenium Inorganic materials 0.000 claims description 2
- 229960003495 thiamine Drugs 0.000 claims description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 2
- 235000010374 vitamin B1 Nutrition 0.000 claims description 2
- 239000011691 vitamin B1 Substances 0.000 claims description 2
- 235000019158 vitamin B6 Nutrition 0.000 claims description 2
- 239000011726 vitamin B6 Substances 0.000 claims description 2
- 235000019154 vitamin C Nutrition 0.000 claims description 2
- 239000011718 vitamin C Substances 0.000 claims description 2
- 235000019166 vitamin D Nutrition 0.000 claims description 2
- 239000011710 vitamin D Substances 0.000 claims description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 2
- 235000019165 vitamin E Nutrition 0.000 claims description 2
- 239000011709 vitamin E Substances 0.000 claims description 2
- 229940046009 vitamin E Drugs 0.000 claims description 2
- 229940011671 vitamin b6 Drugs 0.000 claims description 2
- 229940046008 vitamin d Drugs 0.000 claims description 2
- 239000011701 zinc Substances 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 claims description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims 1
- 108010073771 Soybean Proteins Proteins 0.000 claims 1
- 239000005862 Whey Substances 0.000 claims 1
- 102000007544 Whey Proteins Human genes 0.000 claims 1
- 108010046377 Whey Proteins Proteins 0.000 claims 1
- 235000012054 meals Nutrition 0.000 claims 1
- 235000008935 nutritious Nutrition 0.000 claims 1
- 235000019710 soybean protein Nutrition 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 abstract description 34
- 230000002611 ovarian Effects 0.000 abstract description 13
- 230000036592 analgesia Effects 0.000 abstract description 8
- 230000002708 enhancing effect Effects 0.000 abstract description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 52
- 206010016256 fatigue Diseases 0.000 description 32
- 241000699670 Mus sp. Species 0.000 description 31
- 239000002504 physiological saline solution Substances 0.000 description 27
- 238000010586 diagram Methods 0.000 description 24
- 230000000694 effects Effects 0.000 description 24
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 23
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 22
- 239000008280 blood Substances 0.000 description 22
- 201000010099 disease Diseases 0.000 description 22
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 22
- 239000000243 solution Substances 0.000 description 22
- 230000008961 swelling Effects 0.000 description 21
- 210000004369 blood Anatomy 0.000 description 20
- 230000037396 body weight Effects 0.000 description 20
- 210000001672 ovary Anatomy 0.000 description 20
- 238000002474 experimental method Methods 0.000 description 19
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 18
- 241001247821 Ziziphus Species 0.000 description 18
- 239000000523 sample Substances 0.000 description 18
- 210000004291 uterus Anatomy 0.000 description 18
- 210000004185 liver Anatomy 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 12
- 210000000952 spleen Anatomy 0.000 description 12
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 11
- 230000000202 analgesic effect Effects 0.000 description 11
- 230000002929 anti-fatigue Effects 0.000 description 11
- 230000007812 deficiency Effects 0.000 description 11
- 230000002401 inhibitory effect Effects 0.000 description 11
- 229960003387 progesterone Drugs 0.000 description 11
- 239000000186 progesterone Substances 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 10
- 238000002835 absorbance Methods 0.000 description 10
- 230000036407 pain Effects 0.000 description 10
- COXVTLYNGOIATD-HVMBLDELSA-N CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O Chemical compound CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O COXVTLYNGOIATD-HVMBLDELSA-N 0.000 description 9
- 229960000583 acetic acid Drugs 0.000 description 9
- 230000003110 anti-inflammatory effect Effects 0.000 description 9
- 239000000679 carrageenan Substances 0.000 description 9
- 235000010418 carrageenan Nutrition 0.000 description 9
- 229920001525 carrageenan Polymers 0.000 description 9
- 229940113118 carrageenan Drugs 0.000 description 9
- 210000004246 corpus luteum Anatomy 0.000 description 9
- 229960003699 evans blue Drugs 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 230000009182 swimming Effects 0.000 description 9
- 239000009916 yin-huang Substances 0.000 description 9
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 9
- 208000000114 Pain Threshold Diseases 0.000 description 8
- 239000002775 capsule Substances 0.000 description 8
- 230000034994 death Effects 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 210000000056 organ Anatomy 0.000 description 8
- 230000037040 pain threshold Effects 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 206010061218 Inflammation Diseases 0.000 description 7
- 210000002683 foot Anatomy 0.000 description 7
- 238000003304 gavage Methods 0.000 description 7
- 238000012449 Kunming mouse Methods 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 230000032683 aging Effects 0.000 description 6
- 230000003712 anti-aging effect Effects 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 230000018109 developmental process Effects 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 230000004054 inflammatory process Effects 0.000 description 6
- 210000002394 ovarian follicle Anatomy 0.000 description 6
- 210000001215 vagina Anatomy 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 5
- 206010052428 Wound Diseases 0.000 description 5
- 229960001138 acetylsalicylic acid Drugs 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000035479 physiological effects, processes and functions Effects 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 206010059013 Nocturnal emission Diseases 0.000 description 4
- 206010003549 asthenia Diseases 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 230000004856 capillary permeability Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 239000012362 glacial acetic acid Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 4
- 229960000907 methylthioninium chloride Drugs 0.000 description 4
- 230000016087 ovulation Effects 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 210000003371 toe Anatomy 0.000 description 4
- 239000008096 xylene Substances 0.000 description 4
- 240000006409 Acacia auriculiformis Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 244000126002 Ziziphus vulgaris Species 0.000 description 3
- 210000000683 abdominal cavity Anatomy 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 210000005069 ears Anatomy 0.000 description 3
- 239000002662 enteric coated tablet Substances 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000004570 mortar (masonry) Substances 0.000 description 3
- 230000001603 reducing effect Effects 0.000 description 3
- 239000012266 salt solution Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 229930040373 Paraformaldehyde Natural products 0.000 description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000001147 anti-toxic effect Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 230000012173 estrus Effects 0.000 description 2
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 2
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 2
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 238000009661 fatigue test Methods 0.000 description 2
- -1 filter Cross Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 238000007731 hot pressing Methods 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 208000021822 hypotensive Diseases 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 238000001000 micrograph Methods 0.000 description 2
- 230000004768 organ dysfunction Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 229920002866 paraformaldehyde Polymers 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 235000002020 sage Nutrition 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000000932 sedative agent Substances 0.000 description 2
- 230000001624 sedative effect Effects 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 238000011121 vaginal smear Methods 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- UBLAMKHIFZBBSS-UHFFFAOYSA-N 3-Methylbutyl pentanoate Chemical compound CCCCC(=O)OCCC(C)C UBLAMKHIFZBBSS-UHFFFAOYSA-N 0.000 description 1
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000272816 Anser cygnoides Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 1
- 241000206575 Chondrus crispus Species 0.000 description 1
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 description 1
- 240000004307 Citrus medica Species 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010058359 Hypogonadism Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- XZTYGFHCIAKPGJ-UHFFFAOYSA-N Meclofenoxate Chemical compound CN(C)CCOC(=O)COC1=CC=C(Cl)C=C1 XZTYGFHCIAKPGJ-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 206010036872 Prolonged labour Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 229940025084 amphetamine Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000003567 ascitic fluid Anatomy 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000009193 crawling Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000007908 dry granulation Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 210000000624 ear auricle Anatomy 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 108010084652 homeobox protein PITX1 Proteins 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 239000006101 laboratory sample Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229960003442 meclofenoxate Drugs 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 238000011206 morphological examination Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000011599 ovarian follicle development Effects 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 125000003748 selenium group Chemical group *[Se]* 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 230000002557 soporific effect Effects 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 238000004506 ultrasonic cleaning Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000009306 yunnan baiyao Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of preparation method for being used to alleviate the preparation of physical fatigue, specifically comprise the following steps:A, raspberry, sealwort, radix polygonati officinalis, spina date seed, matrimony vine and jujube are taken by prescription portion rate, added water to cook 3 times, each 1h, extract solution is made;B, obtained extract solution in above-mentioned steps a is collected, filtration, the extract solution of 3 times is merged, concentrating the filtrate to needs concentration, is cooled to room temperature;C, using the extracting method of water extraction and alcohol precipitation method, it is slowly added to ethanol that concentration is 95% and quickly stirs, the alcohol content for making extract solution is 50%, and 12h is placed in sealing, centrifuges to obtain supernatant, reclaims ethanol;D, supernatant is collected, through being dried under reduced pressure at a temperature of 60 DEG C to dry cream, plant extracts is made after crushing;E, particle product or powder is made in plant extracts.The present invention have alleviate physical fatigue and improve energy healthcare function, can enriching yin and nourishing kidney, QI invigorating analgesia, keep or enhancing ovarian function, no dependence.
Description
Technical field
The invention belongs to food technology field, particularly relates to a kind of preparation for being used to alleviate the preparation of physical fatigue
Method.
Background technology
Fatigue is that body is crossed and used or function caused by transfiniting reduces and the state of body discomfort occurs, is mainly shown as god
Tired power, have a dizzy spell, insomnia and dreamful sleep, the symptom such as tinnitus is forgetful, have a pain in the back, epilation, poliosis and women's early ageing.
If cannot recover in time after fatigue generation, gradually accumulation, can cause to overwork, and body occurs under endocrine disturbance, immunity
Drop, or even there is organic disease, it can seriously pose a health risk.Modern medicine proves that fatigue can cause human internal environment to dislike
Change, free radical increases, cell ageing, organ dysfunction decline.And human body cell crosses presenility, decline etc. is to lead to organ dysfunction too early
Cause the important root of people's aging.
At present, commercially available antifatigue chemicals and biological products such as amphetamine, meclofenoxate, Mo Dafeini, coffee
Coffee because, polyactin etc. delay fatigue occur and dispelling fatigue in terms of have preferable effect, but occur many bad anti-
Should, such as cardiovascular harmful effect, disturb sleep, be abalienation, additive, causing clinical application to limit to.In Chinese tradition
Medicine payes attention to transferring the immunity of human body itself, reaches anti-fatigue ability, and to antifatigue, raising energy, anti-aging aspect has
Advantageous advantage, while there is the characteristics of safe and effective, toxic side effect is small.Therefore, develop with toxic side effect it is small,
Curative effect is good, can be long-term use of the advantages that, can alleviate physical fatigue, improve the Chinese medicine and health food of energy by with huge city
Field development potentiality.
Modern Chinese medicine thinks that fatigue is a name of disease, there is its etiology and pathogenesis, is clinically common disease, frequently-occurring disease, is necessary
The new disease paid attention to, is attributed to inferior health category, is related to the vital organs of the human body, mainly based on spleen, liver, kidney.Its tired disease mainly shows
For qi-blood deficiency, weakness of the spleen and the stomach, deficiency of kidney-essence, yin asthenia generating intrinsic heat, therefore treat fatigue and aging should be based on " qi-restoratives ", suitable apparatus
There are the Chinese medicine or Chinese prescription of qi-blood tonifying, strengthening the spleen and stomach, kidney tonifying, essence replenishing, nourishing Yin and clearing heat and other effects.
Traditional Chinese medicine thinks that the kidney being the origin of congenital constitution, evaporates kidney by kidney yang again for the root of organ yin-yang, kidney controlling essence storage, kidney essense
The moon produces kidney qi, and kidney qi can subsidize, promote, coordinating the negative and positive of whole body internal organs, and determines the growth of human body, development, reproduction, declines
Always, dead life process.Each process grow or the warp of the situation that fails, especially women, band, tire, production etc. are special
Physiology course it is whether normal, both depend on the prosperity and decline profit and loss of kidney essense and kidney qi.Theory of traditional Chinese medical science thinks that kidney deficiency is mainly reflected in waist
Knee joint soreness, leg are soft, Hiccough and deaf, tooth falling out, insomnia and dreamful sleep, hectic fever night sweat, hypogona dism, man is simultaneous sees seminal emission, woman
Through less, Amenorrhea or early ageing etc., its symptom and fatigue in modern medical theory or the symptom basic one of chronic fatigue syndrome
Cause, be all the performance of human physiology hypofunction.Therefore, want to alleviate physical fatigue, improve energy, health care and prevent aging
Deng should all start with conditioning from tonic kidney essense kidney qi.
The present invention is according to 6 kinds of medicine foods such as theory of traditional Chinese medical science reasonable compatibility raspberry, sealwort, radix polygonati officinalis, spina date seed, matrimony vine, jujube
Homologous medicinal material.Prescription has the effect of same tonifying Qi god, YIN and YANG balance regulating, QI invigorating righting, filling liver kidney, can alleviate CKD and become and each
The card of kidney qi deficiency, alleviates physical fatigue caused by kind disease, improves human body energy, prevents early ageing, promotes human body various functions extensive
It is multiple.Raspberry invigorates the kidney and stops nocturnal emission establishing-Yang contracting urine in the present invention, nourishes the liver to improve visual acuity as monarch drug in a prescription.Sealwort, radix polygonati officinalis boosting qi and nourishing yin moistening lung, kidney-nourishing are good for
Spleen, promote the production of body fluid to quench thirst as ministerial drug.Spina date seed nourishing heart tonifying liver, antitoxic heart-soothing and sedative;Matrimony vine is nourishing liver and kidney, benefiting shrewd head;Jujube tonifying middle-Jiao and Qi,
Nourishing blood and tranquilization, three are adjutant altogether.Complete square all medicines share, plays kidney and spleen invigorating, nourishing heart tonifying liver, QI invigorating righting is gone with eliminating evil, heresy altogether
Just from peace and disease amelioration or even to more.The document report of identical with the present invention prescription and its preparation is there is no at present.
The content of the invention
The present invention is in order to overcome the shortcomings of the prior art, there is provided a kind of preparation for being used to alleviate the preparation of physical fatigue
Method, there is the significant effect for alleviating physical fatigue using preparation made from the inventive method, being capable of enriching yin and nourishing kidney, QI invigorating town
Bitterly, keep or strengthen ovarian function, most crowds can be widely used in.
The purpose of the present invention is achieved by the following technical solution:A kind of preparation for being used to alleviate the preparation of physical fatigue
Method, the preparation method specifically comprise the following steps:
A, raspberry, sealwort, radix polygonati officinalis, spina date seed, matrimony vine and jujube are taken by prescription portion rate, added water to cook 3 times, each 1h, made
Obtain extract solution;
B, obtained extract solution in above-mentioned steps a is collected, filtration, the extract solution of 3 times is merged, it is dense to concentrate the filtrate to needs
Degree, is cooled to room temperature;
C, using the extracting method of water extraction and alcohol precipitation method, it is slowly added to ethanol that concentration is 95% and quickly stirs, make containing for extract solution
Alcohol amount is 40~70%, and preferable alcohol content is 50%, and 12h is placed in sealing, centrifuges to obtain supernatant, reclaims ethanol;
D, supernatant is collected, through being dried under reduced pressure at a temperature of 60 DEG C to dry cream, plant extracts is made after crushing;
E, particle product or powder is made in plant extracts.
The preparation method of particle product is in preparation:Obtained plant extracts in above-mentioned steps d is taken, adds additives,
Mix, softwood is made with the ethanol that concentration is 80%, crosses 10 mesh medicines sieve, is dried at a temperature of 60 DEG C, whole grain, packing;Whole grain institute
Medicine sieve is 10 mesh sieves and 65 mesh sieves.
The preparation method of powder is in preparation:Preparation method in step d is changed to collect supernatant, adds additives,
Constant volume is filtered, dispensed, sterilize into the volume of needs;Sterilizing methods are gone out using boiling sterilization, flowing steam sterilization method or hot pressing
Bacterium method.
Mixed in the step a by the raw material of following parts by weight:1~10 part of raspberry, 1~8 part of sealwort, radix polygonati officinalis 1
0~3 part of~8 parts, 1~6 part of spina date seed, 0~3 part of matrimony vine and jujube.Preferably, 4~8 parts of raspberry, 3~5 parts of sealwort, radix polygonati officinalis
1~2 part of 3~5 parts, 2~4 parts of spina date seed, 1~2 part of matrimony vine and jujube;Most preferably, 6 parts of raspberry, 4 parts of sealwort, radix polygonati officinalis 4
2 parts of part, 3 parts of spina date seed, 2 parts of matrimony vine and jujube.
In the step a, it is 8~12 times of raw material gross weight to decoct amount of water for the first time, after twice amount of water be original
Expect gross weight 6~10 times.Preferably, it is 12 times of raw material gross weight to decoct amount of water for the first time, after twice amount of water be original
Expect gross weight 10 times.
Additives are any one in the mixture of dietary supplement, filler, preservative, preservative and flavouring
Kind or a variety of mixtures mixed with arbitrary proportion, the filler are the auxiliary material for meeting Chinese food laws and regulations requirement.
Dietary supplement is mineral matter, vitamin, natto, any one or more in protein powder arbitrarily to compare
The mixture that example mixes;The mineral matter is selenium, zinc, calcium, magnesium, potassium, iron, chromium, any one or more in manganese to appoint
The mixture that meaning ratio mixes;The vitamin is beta carotene, vitamin B1, vitamin B6, vitamin C, vitamin
D, the mixture that any one or more in vitamin E is mixed with arbitrary proportion;The protein powder separates for soybean
Any one or more mixture mixed with arbitrary proportion in albumen, lactalbumin, pea protein, collagen.
Raspberry:It is sweet can help, acid can restrain, warm-natured without scorching, kidney-replenishing and the disadvantage without impairment of yin, prevent prolapse and without sluggish
Evil, and mend can be solid, beneficial to the work(of lower envelope Tibetans, be apt to control the card of kidney deficiency not admittedly.Representative medicine of the raspberry as the establishing-Yang that invigorates the kidney and stops nocturnal emission,
Clinically it is usually used in treating neurasthenia, emission and spermatorrhea, premature ejaculation impotence, enuresis frequent micturition, consumptive disease, mesh is secretly dim-sighted to wait card.Pharmacology
It is demonstrated experimentally that raspberry has anti-mutagenesis, anti-inflammatory is anti-oxidant, improving studing ability, anti-aging, strengthens immune wait and makees
With.
Sealwort:It is sweet, put down.Returns spleen, lung, kidney channel.With boosting qi and nourishing yin, invigorating the spleen, moistening lung, the effect of kidney-nourishing.For treating spleen
Stomach Qi deficiency, fatigue and asthenia, deficiency of stomach-Yin, dry deficiency of food, deficiency syndrome of the lung cough caused by dryness, overstrain cough hemoptysis, asthenia of essence and blood, soreness and weakness of waist and knees, beard and hair are early
In vain, Heat Diabetes etc. is demonstrate,proved, and is one of conventional nourishing medicine of the traditional Chinese medical science.Modern study shows that sealwort has resisting pathogenic microbes(Carefully
Bacterium, fungi, virus etc.), reducing blood lipid is hypoglycemic, hypotensive, and anti-aging is antitumor, antifatigue, radioresistance, resist oxygen lack, antioxygen
Change activity, enhancing is immune, and leucocyte caused by antagonism endoxan declines, strong neutrophil phagocytosis, expands coronal dynamic
The effect such as arteries and veins, increase coronary blood flow.
Radix polygonati officinalis:《Sheng Nong's herbal classic》It is classified as top grade.It is sweet, it is slightly cold.Attach to the lung and stomach meridians.With nourishing yin to moisten dryness, the work(to promote the production of body fluid to quench thirst
Effect.For treating the cards such as lung stomach-Yin wound, cough caused by dryness-heat, dry throat and mouth, Heat Diabetes.Modern study shows that radix polygonati officinalis, which has, improves
Immunity, cardiac stimulant is hypoglycemic, reducing blood lipid, extends the effect such as animal lifespan.
Spina date seed:《Compendium of Materia Medica》It is classified as top grade.It is sweet, sour, put down.Return liver, courage, the heart channel of Hang-Shaoyin.With nourishing heart tonifying liver, calming heart
Calm the nerves, arrest sweating, the effect of promoting the production of body fluid.For treating the card such as restlessness of asrhenia type and insomnia, horrified to much dream, body void hidrosis, injury thirst.Modern study
Show, spina date seed has tranquilizing soporific, and analgesia, anticonvulsion, reducing blood lipid, platelet aggregation-against, enhancing is immune, hypotensive, resists and lacks
Oxygen, resist myocardial ischemia, anti-arrhythmia cordis, anti-aging, the effect such as radioresistance.
Matrimony vine:First recorded in《Sheng Nong's herbal classic》It is listed in top grade.It is sweet, put down.Return liver and kidney channel.With nourishing liver and kidney, strengthening the essence is bright
Purpose effect.For treating consumption consumptive loss, soreness of waist and knee joint, dizziness and tinnitus, impotence and seminal emission, Heat Diabetes, blood deficiency chlorosis, blurred vision is not
It is bright to wait card.
Jujube:First recorded in《Sheng Nong's herbal classic》It is listed in top grade.It is sweet, temperature.Returns spleen, stomach, the heart channel of Hang-Shaoyin.With tonifying middle-Jiao and Qi, support
The effect of blood and tranquilizing mind.For treating the card such as spleen eating less, weak loose stool, hysteria of womam.
Particle product provided by the invention, powder, comprising pharmaceutically acceptable additives, including it is filler, anti-
In rotten agent, dietary supplement any one, the mixture that is mixed with arbitrary proportion of two kinds and the above.Wherein fill
Agent is to meet the auxiliary material of Chinese food laws and regulations requirement, include but are not limited to ethanol, dextrin, starch, sucrose, glucose, honey,
Mannitol, xylitol, Steviosin, lactose, fructose, protein sugar, maltitol, Aspartame, essence for food spices, citron
It acid, can be used alone, also can be combined and use.
Preservative is the conventional auxiliary material for meeting national Specification, includes but are not limited to peppermint oil, cinnaldehydrum, folium eucalypti
Oil, benzoic acid, sodium benzoate, methyl hydroxybenzoate, ethylparaben, propylben, butyl hydroxybenzoate, sorbic acid, can be independent
Use, also can be combined and use.
The functional food of the present invention, it is to be processed by the raw material for forming above-mentioned formula by extraction or other modes, system
Into intermediate raw material, it is necessary to when add pharmaceutically acceptable additives, be made according to the routine techniques of galenic pharmacy.Described centre
Raw material can be obtained by extracting raw material respectively, can also be obtained by extracting raw material jointly, can also be obtained by other means
The methods of arriving, carrying, chromatograph such as crushing, squeezing, grinding, sieving, diacolation, extraction, water extraction, alcohol extracting, ketone obtains, these intermediate raw materials
Can be medicinal extract form, can be dry extract or liquid extract, according to preparation it is different need to determine to be made it is different dense
Degree.
The present invention is using the extract mixtures of raspberry, sealwort, radix polygonati officinalis, spina date seed, matrimony vine and jujube as raw material, system
Into particle product or powder.Particle product or powder have and alleviate physical fatigue according to Basic Theories of Chinese Medicine prescription,
Improve energy healthcare function, can enriching yin and nourishing kidney, QI invigorating analgesia, keep or enhancing ovarian function.The present invention draws to many reasons
The fatigue and sub-health population risen has obvious antifatigue effect, no obvious adverse reaction, no dependence;Simple process is easy
OK, production cost is controllable, is advantageous to industrialized production, and a variety of formulations can be made as needed.
The present invention also has very big purposes in terms of physical fatigue is alleviated, improve energy and anti-aging.With chronic tired
The most liver kidney deficiency of the crowd of labor syndrome or long labor prolonged illness is weak, insufficiency of vital energy and blood, preferably combine invigorate the kidney and stop nocturnal emission, Yangyin Rougan liver, tonifying Qi live
Blood Chinese medicine.The health food presses traditional Chinese medical theory scientific composition, has no side effect safely.We are using raspberry as monarch drug in a prescription, kidney tonifying again
Gas, controlling nocturnal emission with astringent drugs support marrow, with dispel it is tired refresh oneself, treatment kidney wound fatigue card.Minister is with the sealwort of boosting qi and nourishing yin kidney-nourishing, jade that nourishing Yin and promoting production of body fluid is moisturized
Bamboo, play tonifying Qi enriching yin, the work(of moistening lung invigorating the spleen altogether, with dispel it is tired repose, treatment spleen and lung wound fatigue card.Assistant spina date seed nourishing heart tonifying liver,
Antitoxic heart-soothing and sedative, jujube tonifying middle-Jiao and Qi, nourishing blood and tranquilization, with the tired benefit god that dispels, treat grieved fatigue card;Spina date seed is nourishing liver and kidney, strengthening the essence
Improving eyesight, with tired inducing resuscitation of dispelling, treatment liver wound fatigue card.All medicines share, benefit profit is proper, and gas fills arteries and veins and answered, and internal organs reconcile, and fatigue self solves.
The beneficial effects of the invention are as follows:Given efficacy and pharmaceutical value of the invention based on above-mentioned natural plants, with certainly
Right plant, traditional health-preserving method is combined with theory of medicine, is conceived to and alleviates physical fatigue, improve energy, anti-aging
Deng by 6 kinds of raspberry, sealwort, radix polygonati officinalis, spina date seed, matrimony vine and jujube medicinal and edible plant optimization compoundings.On the one hand, qi-restoratives is solid
Member, body is nourished, empty to mend, canonical is prosperous, and fatigue is removed certainly;On the other hand, tonifying kidney and strengthening yang, flourish muscle support marrow, and brain has been supported, and bone obtains
Strong, fatigue can disappear.The present invention has further the advantage that:It is in good taste, safely and effectively, it is adapted to most of crowds to drink for a long time;Raw material
Integration of drinking and medicinal herbs Chinese medicine or natural food are all derived from, safely and effectively, no ill-effect, nutrition is comprehensive.
Brief description of the drawings
Fig. 1 is schematic diagram of the particle product of the present invention to the analgesic activity of hot plate method induced pain mouse;
Fig. 2 is schematic diagram of the particle product of the present invention to the analgesic activity of glacial acetic acid induced pain mouse;
Fig. 3 is the schematic diagram of influence of the particle product of the present invention to mice auricle swelling;
Fig. 4 is the linear dependence figure between absorbance A value and Evans blue seepage discharge of the present invention;
Fig. 5 is the schematic diagram of influence of the particle product of the present invention to mouse capillary permeability;
Fig. 6 is the schematic diagram of influence of the particle product of the present invention to mouse toes swelling;
Fig. 7 is the schematic diagram of influence of the particle product of the present invention to mouse swimming time;
Fig. 8 is schematic diagram of the particle product of the present invention to the influence of keratinocyte on vagina;
Fig. 9 is the linear dependence figure between absorbance OD values of the present invention and progesterone P amounts (ng/mL);
Figure 10 is the schematic diagram of influence of the particle product of the present invention to female mice progesterone P content;
Figure 11 is the schematic diagram of influence of the particle product of the present invention to female mice body weight, uterus and ovary weight and organ index;
Figure 12 is uterus sections micrograph of the present invention, and HE dyes × 2 times;
Wherein:A, blank group;B, particle product low dose group;C, particle product middle dose group;D, particle product high dose group;e、
Bolus for woman diseases group;
Figure 13 is ovarian sections micrograph of the present invention;
Wherein:A, the full cyclogram of ovarian sections(× 1 times);B, blank group(× 10 times);C, particle product low dose group(×10
Times);D, particle product middle dose group(× 10 times);E, particle product high dose group(× 10 times);F, bolus for woman diseases group(× 10 times);
G, ovarian follicle form(× 40 times);
Figure 14 is the schematic diagram of influence of the particle product of the present invention to female mice Follicles sum and corpus luteum number.
Embodiment
Below in conjunction with the drawings and specific embodiments, the invention will be further described.
A kind of preparation method for being used to alleviate the preparation of physical fatigue, the preparation method specifically comprise the following steps:
A, raspberry, sealwort, radix polygonati officinalis, spina date seed, matrimony vine and jujube are taken by prescription portion rate, added water to cook 3 times, each 1h, made
Obtain extract solution;
B, obtained extract solution in above-mentioned steps a is collected, filtration, the extract solution of 3 times is merged, it is dense to concentrate the filtrate to needs
Degree, is cooled to room temperature;
C, using the extracting method of water extraction and alcohol precipitation method, it is slowly added to ethanol that concentration is 95% and quickly stirs, make containing for extract solution
Alcohol amount is 40~70%, and preferable alcohol content is 50%, and 12h is placed in sealing, centrifuges to obtain supernatant, reclaims ethanol;
D, supernatant is collected, through being dried under reduced pressure at a temperature of 60 DEG C to dry cream, plant extracts is made after crushing;
E, particle product or powder is made in plant extracts.
The preparation method of particle product is in preparation:Obtained plant extracts in above-mentioned steps d is taken, adds additives,
Mix, softwood is made with the ethanol that concentration is 80%, crosses 10 mesh medicines sieve, is dried at a temperature of 60 DEG C, whole grain, packing;Whole grain institute
Medicine sieve is 10 mesh sieves and 65 mesh sieves.
The preparation method of powder is in preparation:Preparation method in step d is changed to collect supernatant, adds additives,
Constant volume is filtered, dispensed, sterilize into the volume of needs;Sterilizing methods are gone out using boiling sterilization, flowing steam sterilization method or hot pressing
Bacterium method.
Mixed in the step a by the raw material of following parts by weight:1~10 part of raspberry, 1~8 part of sealwort, radix polygonati officinalis 1
0~3 part of~8 parts, 1~6 part of spina date seed, 0~3 part of matrimony vine and jujube.Preferably, 4~8 parts of raspberry, 3~5 parts of sealwort, radix polygonati officinalis
1~2 part of 3~5 parts, 2~4 parts of spina date seed, 1~2 part of matrimony vine and jujube;Most preferably, 6 parts of raspberry, 4 parts of sealwort, radix polygonati officinalis 4
2 parts of part, 3 parts of spina date seed, 2 parts of matrimony vine and jujube.
In the step a, it is 8~12 times of raw material gross weight to decoct amount of water for the first time, after twice amount of water be original
Expect gross weight 6~10 times.Preferably, it is 12 times of raw material gross weight to decoct amount of water for the first time, after twice amount of water be original
Expect gross weight 10 times.
Embodiment 1:Powder
Formula:Raspberry 60g, sealwort 40g, radix polygonati officinalis 40g, spina date seed 30g, matrimony vine 10g, jujube 10g and sodium benzoate 0.6g.
Preparation method:Raspberry, sealwort, radix polygonati officinalis, spina date seed, matrimony vine, jujube are taken, adds water to cook 3 times, each 1h, first
Secondary amount of water is 12 times of above-mentioned raw materials total amount, after twice amount of water be 10 times of above-mentioned raw materials total amount.Collect extract solution, filter
Cross, extract solution three times is merged, filtrate is concentrated into finite concentration, is cooled to room temperature, is slowly added to 95% ethanol and quickly stirs
Mix, it is 50% to make alcohol content, and 12h is placed in sealing, centrifuges to obtain supernatant, adds additives, and constant volume filters into certain volume.Point
Dress.Sterilizing.
Embodiment 2:Particle product
Formula:Raspberry 60g, sealwort 40g, radix polygonati officinalis 40g, spina date seed 30g, matrimony vine 10g, jujube 10g, DEXTRIN g, sucrose 80g
With 80% ethanol 10mL.
Preparation method:Raspberry, sealwort, radix polygonati officinalis, spina date seed, matrimony vine, jujube are taken, adds water to cook 3 times, each 1h, first
Secondary amount of water is 12 times of above-mentioned raw materials total amount, after twice amount of water be 10 times of above-mentioned raw materials total amount.Collect extract solution, filter
Cross, extract solution three times is merged, filtrate is concentrated into finite concentration, is cooled to room temperature, is slowly added to 95% ethanol and quickly stirs
Mix, it is 50% to make alcohol content, and 12h is placed in sealing, centrifuges to obtain supernatant, is dried under reduced pressure to dry cream, crushes through 60 DEG C, is added additional
Agent, mix, cross 80 mesh sieves (No. five sieves), using dry granulation, 80% appropriate ethanol is uniformly sprayed into, is made that " hand is pinched agglomerating, refers to
Pressure i.e. dissipate " softwood, then in a manner of extruding by 10 mesh medicines sieve, uniform particle is made, rapidly puts the particle being prepared into
In 60 DEG C of baking oven, 3h is dried.Dry particle is taken, with 10 mesh(No.1 is sieved)With 65 mesh(No. four sieves)Carry out whole grain.Packing.
Embodiment 3:Powder
Formula:Raspberry 60g, sealwort 40g, radix polygonati officinalis 40g, spina date seed 30g, matrimony vine 20g, jujube 15g and ethylparaben 0.5g.
Preparation method is the same as embodiment 1.
Embodiment 4:Particle product
Formula:Raspberry 60g, sealwort 40g, radix polygonati officinalis 40g, spina date seed 30g, matrimony vine 20g, jujube 15g, dextrin 90g, Steviosin
0.04g and 80% ethanol 10mL.Preparation method is the same as embodiment 2.
The alleviation physical fatigue of Chinese medicine preparation of the present invention, energy is improved, keep or strengthen ovarian function, QI invigorating analgesic work(
Effect can be proved by following 4 kinds of pharmacodynamic experiments:Experiment I:The analgesic experiment of hot plate method and writhing method;Experiment II:Caused by dimethylbenzene xylene
The anti-inflammatory of mice auricle swelling method, mice caused by dimethylbenzene xylene auricle edema method and the experiment of carrageenan induced mice pedal swelling is real
Test;Experiment III:The anti-fatigue test of mouse swimming;Experiment IV:Ovulation induction is tested.
Experiment I:The analgesic experiment of hot plate method and writhing method.
1.1 laboratory samples and reagent
Raspberry(Guangzhou Kang Sheng pharmaceutcal corporation, Ltds, lot number:20160912);Spina date seed(Guangzhou Kang Sheng pharmaceutcal corporation, Ltds, batch
Number:20161005);Sealwort(Guangzhou Kang Sheng pharmaceutcal corporation, Ltds, lot number:20161012);Radix polygonati officinalis(The limited public affairs of Guangzhou health sage's medicine company
Department, lot number 20160928);Jujube(Guangzhou Kang Sheng pharmaceutcal corporation, Ltds, lot number:20161125);Matrimony vine(Guangzhou health sage's medicine company has
Limit company, lot number:20161103)Above medicinal material is accredited as certified products through Chinese medicine institute of Guangdong pharmaceutical university horse swan goose associate professor.It is fixed
Female pellet(Shanxi Guang Yuyuan traditional Chinese medicines Co., Ltd, lot number:139170102);Aspirin enteric coated tablet(The limited public affairs of Bayer medicines and health protection
Department, lot number:BJ32400);Qi and blood recovering capsule(Yunnan Baiyao group mountain of papers seven spends Co., Ltd, lot number:WEA1345);Silver yellow
Grain(Hengsheng Pharmaceutical Co., Ltd., Zhongshan City, lot number:20161007);Progesterone P kits(Shanghai Tong Wei Industrial Co., Ltd.s);
NaCl(Tianjin Zhi Yuan chemical reagent Co., Ltd, lot number:20160710);Dimethylbenzene(Tianjin richness space fine chemistry industry is limited
Company, lot number:20151120);Evans blue(Shanghai Ru Ji biotechnologies Development Co., Ltd, lot number:150722);Irish moss
Glue(Shanghai Mike's woods biochemical technology Co., Ltd, lot number:C10068972);Methylene blue(The limited public affairs of Chinese medicines group chemical reagent
Department, lot number:20151223):4% paraformaldehyde fixer(Wuhan bio tech ltd of Google, lot number:20160314);Ice
Acetic acid(Tianjin all generations Chemical Co., Ltd., lot number:20140808);Above reagent is that analysis is pure.
1.2 experimental animal
SPF level Kunming mouses, male and female dual-purpose, weight (20 scholar 2) g, provided by Nanfang Medical Univ's Experimental Animal Center,
Production licence number SCXK(Guangdong)2016-0041, divide cage to feed according to experimental nature and sex, free choice feeding drinking-water, claim every other day
Weigh sb..22~24 DEG C of room temperature, to humidity 52%~56%.
1.3 instruments and producer
RE-2000A type vacuum rotary evaporators(Shanghai Yarong Biochemical Instrument Plant);SHE-D (III) type circulating water type vavuum pump
(Yuhua Instrument Co., Ltd., Gongyi City);202-2AB type Constant Temp. Ovens(The limited public affairs of Tianjin Stettlen instrument
Department);The mm card punch of diameter 8(Beijing Zhong Shidichuan developments in science and technology Co., Ltd);KQ-300DE numerical control ultrasonic cleaning machines
(Kunshan Ultrasonic Instruments Co., Ltd.);The hole water-bath of HH-S6 constant temperature six(Community of Jin Tan County Jin Cheng Guo Sheng laboratory apparatus factory);YLS-
6A intelligence hot-plate instruments(Shandong Academy of Medical Sciences's equipment station);Ou Nuo shaking tables(Tianjin Ounuo Instrument Co., Ltd.);8 holes
The liquid relief volley of rifle fire(The emerging wound laboratory apparatus of big dragon(Beijing)Co., Ltd);MNT-150 Mei Naite origin digital display callipers(Shanghai Mei Naite
Industrial Co., Ltd.);OLYMPUS CKX41 inversion type biomicroscopes(Beijing development in science and technology Co., Ltd of Zhong Yiguang sections);
The general ELIASAs of ELX800 (Bai Teng Instrument Ltd. of the U.S. (BioTek)).
The preparation of 1.4 samples
Body weight in terms of 60kg, mouse daily dose in terms of 9 times of people, the mouse dosage of positive control drug with
0.2mL/10g is counted, and the mouse dosage of tested particle product particle is in terms of 0.3mL/10g.The specific of sample is formulated as follows:
1. given the test agent is prepared:The particle product that Example 2 is prepared into, add physiological saline(50-60℃)Dissolving, if necessary
It is ultrasonically treated, is configured to basic, normal, high three kinds of concentration(100、150、225mg:1mL)Suspension.Wherein, particle product
9 times of the dosage of middle concentration group equivalent to people's normal dose.
2. Yinhuang Particle sample(59.99mg:1mL)Preparation:Yinhuang Particle is ground in after powder with mortar, weighs 6g
Add physiological saline to 100mL, prepared before use.
3. aspirin enteric coated tablet sample(4.5mg:1mL)Preparation:It is in powder that aspirin enteric coated tablet is ground with mortar
It is last, weigh 0.45g and add physiological saline to be ultrasonically treated if necessary, prepared before use to 100mL.
4. qi and blood recovering capsule sample(13.5mg:1mL)Preparation:After qi and blood recovering capsule goes capsule shells, weigh 0.54g and add life
Salt solution is managed to 40mL, is ultrasonically treated if necessary, prepared before use.
5. bolus for woman diseases sample(81mg:1mL)Preparation:Bolus for woman diseases is ground in after powder with mortar, 3.24g is weighed and adds
(50-60℃)Physiological saline is ultrasonically treated, prepared before use to 40mL.
6. 0.8% acetum:Accurate measuring 0.8mL glacial acetic acid adds distilled water constant volume to face into 100mL volumetric flask
With preceding preparation.
7. 0.5% Evans blue physiological saline:Weigh 0.5g Evans blue powder and be completely dissolved in 100mL physiological saline, pass through
0.22 μm of miillpore filter filtration, prepared before use.
8. 0.8% acetic acid physiological saline:Accurate measuring 0.8mL glacial acetic acid adds physiological saline constant volume to 100mL volumetric flask
In, prepared before use.
9. 1% carrageenan suspension:24h weighs 50mg carrageenan powder and is dissolved in 50mL physiological saline before use, repeatedly
Shaking is ultrasonically treated to without indissoluble thing gel, is placed in 4 DEG C of preservations if necessary.
10. 5% methylene blue solution:95% ethanol solution that 0.5g methylene blue powder is completely dissolved in 100mL is weighed, is matched somebody with somebody before use
System.
Experiment I:The analgesic experiment of mouse.
2.1.1 hot plate method:
Take healthy Kunming kind female mice(18-22 g), intelligent hot-plate instrument temperature is adjusted to(55±0.5)DEG C, preheat 10 minutes
Afterwards, female mice 1 is merely placed on hot plate every time, the time required to mouse licks left back foot from putting to occurring(s)As the mouse
Pain threshold, it is qualified to screen(The sufficient time is licked in 5s to 30s)Female mice 75 be only divided into 5 groups, every group 15 by table of random number
Only, respectively physiological saline group(0.2 mL/10 g), aspirin positive controls, particle product low dose group, middle dosage
Group, high dose group.Replication pain threshold before every group of administration, take twice threshold of pain average value as normal pain threshold.Adaptability is fed
After supporting 3 days, relative medicine gavage is carried out by different groups, 1 time a day, claims time body weight every other day, according to body weight by being only administered, continuously
Administration 7 days.Respectively at the pain threshold of 30min, 60min, 90min measurement mouse after last dose, if painless anti-in mouse 60s
Should, take out, calculated by 60s immediately, record result, calculate each group threshold of pain and improve percentage, as a result carried out with SPSS22 between group
T is examined, with P<0.05 is statistically significant.
2.1.2 writhing method:
Take healthy Kunming mouse(18-22 g)75, male and female half and half, it is divided into 5 groups by table of random number, every group 15, distinguishes
For physiological saline group(0.2 mL/10 g), aspirin positive controls, particle product low dose group, middle dose group, high dose
Group.After adaptability is fed 3 days, relative medicine gavage is carried out by different groups, 1 time a day, claims time body weight every other day, according to body weight by
Only it is administered, successive administration 7 days.The 30min after last dose, each mouse are newly prepared by 0.1ml/10g dosage intraperitoneal injection
0.8% acetum, observe and record every mouse in 15min and writhing response occur(Belly shrinks indent, stretches hind leg, stern
Portion raises, crawling)Number, calculate analgesia percentage, as a result carrying out t between group with SPSS22 examines, with P<0.05 is to have
Statistical significance.Analgesia percentage (%)=(The average writhing number of the average writhing number-administration group of saline control group)/
Average writhing number × 100% of saline control group
Experiment II:The anti-inflammatory experiment of mouse.
Mice caused by dimethylbenzene xylene auricle edema method:
Take healthy Kunming mouse(18-22g)105, male and female half and half, it is divided into 7 groups by table of random number, every group 15, distinguishes
Blank group(0.2 mL/10 g physiological saline), model group(0.2 mL/10 g physiological saline), Yinhuang Particle group, aspirin
Group, particle product low dose group, middle dose group, high dose group.After adaptability is fed 3 days, using mice ear anti-inflammatory method, press
Different groups carry out relative medicine gavages, 1 time a day, claim time body weight every other day, according to body weight by being only administered, successive administration 10 days.
0.5h after last dose, in addition to blank group, 0.02ml dimethylbenzene is uniformly applied to the left ear auricle two of every mouse by remaining each group
Face causes inflammation, and auris dextra is not applied as normal control.Neck is taken off after 1h and puts to death each mouse, with diameter 8mm card punch in left ear and auris dextra
Round auricle is laid at same position, and with scales/electronic balance weighing, auris dextra weight is subtracted as swelling using left ear weight, is calculated ear respectively and is swollen
Expansibility and swelling inhibiting rate, t between group is as a result carried out with SPSS22 and examined, with P<0.05 is statistically significant.
Swelling inhibiting rate(%)=(The average swelling of the average swelling-administration group of model group)/(The average swelling of model group)
×100%
Mice caused by dimethylbenzene xylene auricle edema method mouse peritoneal capillary permeability is tested:
Take healthy Kunming mouse(18-22 g)90, male and female half and half, it is divided into 6 groups, every group 15 by table of random number.Respectively
For normal group(The mL/10 g of physiological saline 0.2), model group(The mL/10 g of physiological saline 0.2), Yinhuang Particle group, particle product
Basic, normal, high dosage group.After adaptability is fed 3 days, relative medicine gavage is carried out by different groups, 1 time a day, claims time body every other day
Weight, according to body weight by being only administered, successive administration 10 days.Fasting 12h before last time is administered, after last dose 30min, each mouse
The equal Evans blue physiological saline 0.1ml/10g of tail vein injection 0.5% (filters through miillpore filter), belly is gently rubbed, abdominal cavity is noted immediately
Penetrate 0.8% acetic acid physiological saline 0.2ml/10g(Normal group does not inject acetic acid as control), neck is taken off after 30min and puts to death each mouse,
Abdominal cavity is splitted, with 5ml normal saline flushing numbers, collects washing lotion 10mL, 3000r/min centrifugation 20min, takes supernatant, use is pure
Water school zero, trap is determined at 590nm with ultraviolet specrophotometer(OD values), t between group is as a result carried out with SPSS22 and examined
Test, with P<0.05 is statistically significant.
In addition, azovan blue concentration, method are released according to absorbance A value:It is the two-fold dilution of 0.5% azovan blue solution
And in colorimetric surveys absorbance A value at 590nm on spectrophotometer, it is known that concentration mensuration point replication 2 times, its average is as A
Value, seeks the linear dependence between A values and seepage discharge (μ g/mL), obtains the other Evans blue seepage discharge of each group.Administration group presses down
Rate processed(%)=(Model group absorbance values-administration group absorbance values)/ model group absorbance values × 100%.
Carrageenan induced mice pedal swelling is tested:
Take healthy Kunming mouse(18-22 g)105, male and female half and half, it is divided into 7 groups by table of random number, every group 15, distinguishes
For blank group (mL/10 g of physiological saline 0.2), model group(The mL/10 g of physiological saline 0.2), aspirin group, Yinhuang Particle
Group, particle product low dose group, middle dose group and high dose group.After adaptability is fed 3 days, relative medicine is carried out by different groups
Gavage, 1 time a day, claim time body weight every other day, according to body weight by being only administered, successive administration 10 days.Vernier calliper is first used after last dose
Chi(Precision 0.02mm)The thickness of all mouse left hind vola pedis is surveyed, 1% carrageenan is then subcutaneously injected at left hind vola pedis
Suspension(Every 0.02mL), blank group injection normal saline, cause acute pedal swelling model.1% jiao of measure injection respectively
30min, 1h, 2h, 3h mouse cause the thickness of rear vola pedis after inflammation after fork dish glue suspension, so that sufficient before and after vola pedis thickness and cause are scorching after inflammation
The difference of the thickness of plantar using swelling as Testing index, carries out statistical analysis, investigates medicine Carrageenan as swelling
The influence of induced mice pedal swelling.Next day puts to death mouse after causing inflammation, takes the rear vola pedis of mouse or so, is precisely weighed, left and right vola pedis
Difference is inflammatory swelling degree, calculates mouse pedal swelling inhibiting rate.As a result carry out t between group with SPSS22 to examine, with P<0.05
To be statistically significant.Swelling rate calculation formula: E(%)=(Volume-cause inflammation front volume after cause is scorching)The scorching front volume of/cause ×
100%.Pedal swelling inhibiting rate(%)=(Left foot weight-right lumping weight amount)/ right lumping weight amount × 100%
Experiment III:The anti-fatigue test of mouse swimming.
Take healthy Kunming mouse(18-22 g)75, male and female half and half, it is divided into 5 groups by table of random number, every group 15,
Respectively physiological saline group(0.2 mL/10 g), qi and blood recovering capsule group, particle product low dose group, middle dose group, high dose
Group.After adaptability is fed 3 days, relative medicine gavage is carried out by different groups, 1 time a day, claims time body weight every other day, according to body weight by
Only it is administered, successive administration 10 days.It is administered after 1 h and mouse is put into depth of water 30cm, the swimming trunk that 25 DEG C of water temperature(Specification 72*53*
43cm)Went swimming, 8 every batch.Clean water is changed under per a collection of mouse before water, measures water temperature.Make in whole experiment process
Every mouse four limbs keep motion, if mouse swims in the water surface, four limbs are motionless, are stirred with wooden stick in its near its circumference.Record small
Mouse since swimming to the death time, the power as mice burden swimming exhausts the death time(When doing one's utmost, the death time is more than
During 200min, in terms of 200min).As a result carry out t between group with SPSS22 to examine, with P<0.05 is to have statistics meaning.
Experiment IV:The ovulation induction experiment of mouse.
Take the healthy teenage female mice of Kunming kind(18-22 g)75, random is 5 groups, every group 15, respectively physiology
Salt solution group(0.2 mL/10 g), bolus for woman diseases group, decoction particles product low dose group, middle dose group, high dose group are wanted well.Adaptability
After feeding 5 days, relative medicine gavage is carried out by different groups, 1 time a day, claims time body weight every other day, according to body weight by being only administered, even
Continuous administration 15 days(3-4 cycle).Empirically require to carry out the investigation of indices, t between group is as a result carried out with SPSS22 and examined
Test, with P<0.05 is statistically significant.
2.4.1 vagina superficial cell inspection:
After 10d is administered, daily at 9 points in the morning, continuously daily vaginal smear 1 time of each group mouse.By aseptic cotton carrier physiology salt
Mouse vagina is inserted after water-soaked, takes out after fully dipping secretion, is gently rolled on slide, secretion is equably coated with
In on slide, natural air drying, dyed with 5% methylene blue solution (preparation of 95% ethanol solution) newly configured, it is unnecessary to be gone after 2h with water drift
Dyeing liquor, wait to do, be placed in the situation of biology microscope Microscopic observation vagina superficial cell, continuous 1 oestrous cycle of smear
(5d).Be more than the smear gross area using superficial cell area 50% is used as positive criterion, calculating positive rate.
2.4.2 progesterone P puts inspection-free survey in serum:
After last dose 1h, each group mouse takes blood with plucking eyeball method, taken blood is put after 4 DEG C of environment stand 2h, centrifugation
(3000 r/min, 10min), serum is separated, is operated according to kit specification.Determine the content of progesterone P in mice serum.It is pregnant
Ketone P ELISAs(ELISA)Concrete operation step it is as follows:
1. the sample-adding of standard items:Setting standard sample wells and sample well, standard sample wells respectively add the μ L of standard items 50 of various concentrations.
2. it is loaded:Blank well is set respectively(Blank control wells are not added with sample and enzyme marking reagent, and remaining each step operation is identical)、
Testing sample hole.First add the μ L of sample diluting liquid 40 in testing sample hole on enzyme mark coating plate, then again plus with the μ L of test sample product 10
(The final dilution factor of sample is 5 times).Sample is added on ELISA Plate bottom hole portion by sample-adding, is tried not to touch hole wall, is gently rocked mixed
It is even.
It is 3. enzyme-added:Add the μ L of enzyme marking reagent 100 per the hole liquid relief volley of rifle fire, in addition to blank is empty.
4. incubate:With shrouding film shrouding, rearmounted 37 DEG C incubate 60 minutes.
5. match somebody with somebody liquid:It is standby after being diluted with 20 times of 20 times of concentrated cleaning solution distilled water.
6. wash:Shrouding film carefully is opened, discards liquid, is dried, cleaning solution is filled it up with per hole, is discarded after standing 30 seconds, such as
This is repeated 5 times, and pats dry.
7. develop the color:Per Kong Xianjia developer A50 μ L, then add developer B50 μ L, gently concussion mixes, 37 DEG C of lucifuge colour developings
15 minutes.
8. terminate:Add the μ L of terminate liquid 50, terminating reaction per hole(Now blueness turns blueness immediately).
9. determine:Returned to zero with blank well, 450nm wavelength sequentially measures the absorbance in each hole(OD)Value.Measure should add end
Only carried out after liquid in 15 minutes.
10. calculate:Using the concentration of reference material as abscissa, OD values are abscissa, draw standard curve, draw linear regression
Equation, corresponding concentration is calculated according to the OD values of sample, multiplied by with the actual concentrations of extension rate, as sample.
2.4.3 uterus, ovary weight and assessment of indices
Pluck after eyeball takes blood and rapidly put to death mouse, split abdominal cavity, take out uterus and both sides ovary, peel off surrounding tissue and fat
Fat, rapidly with electronic balance weighing uterus and the weight in wet base of ovary.And it is converted into organ index:Uterus index=uterus weight (mg)
/ 100g body weight, ovarian index=ovary weight (mg)/100 g body weight.
2.4.4 uterus and ovary tissue morphological examination
The fresh uterus taken and ovary tissue sample are fixed with 4% paraformaldehyde fixer, conventional dehydration, waxdip embedding, cut
Piece, HE dyeing.Biology microscope inspection and computer shooting, tissues observed morphological change, and record each in bilateral ovaries section
Level ovarian follicle sum and corpus luteum number.
Experimental result and analysis
Fig. 1 is schematic diagram of the particle product to the analgesic activity of hot plate method induced pain mouse in an embodiment of the invention.
As shown in Figure 1,30min after administration, the pain threshold of the basic, normal, high dosage group of particle product improve percentage and physiology
Salt solution group comparing difference is not statistically significant(P>0.05).60min after administration, particle product low dose group, high dose group
Pain threshold improves percentage and physiological saline group comparing difference is statistically significant(P<0.05);90min after administration, particle product
Middle dose group, the pain threshold of high dose group improves percentage and physiological saline group comparing difference is statistically significant(P<0.05 or P
<0.01), i.e., particle product can improve to some extent hot plate method pain model mouse pain threshold, reduce pain reaction number, its
Analgesic effect has obvious dose-effect relationship, and the analgesic activity of low dose group is worst.(Note:Compared with physiological saline group:*P<
0.05, * *P<0.01;Compared with aspirin group:▲P<0.05, ▲▲P<0.01.)
Fig. 2 is schematic diagram of the particle product to the analgesic activity of glacial acetic acid induced pain mouse in an embodiment of the invention.
As shown in Figure 2, the basic, normal, high dosage group of particle product can significantly decrease the writhing number of acetic acid induced pain mouse,
It is statistically significant with physiological saline group comparing difference(P<0.01);The incubation period of writhing, particle can be extended to some extent
Product high dose group and physiological saline group comparing difference are statistically significant(P<0.01).In terms of analgesia rate, its analgesic effect tool
There is obvious dose-effect relationship.(Note:Compared with physiological saline group:*P<0.05, * *P<0.01;Compared with aspirin group:▲P
<0.05, ▲▲P<0.01.)
Fig. 3 is the schematic diagram of influence of the particle product to mice auricle swelling in an embodiment of the invention.
Swollen from the figure 3, it may be seen that the basic, normal, high dosage group of particle product can substantially suppress the Mice Auricle as caused by dimethylbenzene
Swollen, anti-inflammatory effect and model group comparing difference are statistically significant(P<0.01), but group difference unobvious(P>0.05);Particle
Product high dose group and aspirin group and Yinhuang Particle group comparing difference are not statistically significant(P>0.05).In terms of inhibiting rate,
Particle product is in certain dose-dependence to the inhibiting rate of auricle edema, and with the increase of dosage, inhibitory action has increased
Trend.(Note:Compared with model group:*P<0.05, * *P<0.01;Compared with aspirin group:▲P<0.05, ▲▲P<
0.01;Compared with Yinhuang Particle group:▼P<0.05, ▼ ▼ P<0.01.)
Fig. 4-5 is the schematic diagram in an embodiment of the invention.Wherein, Fig. 4 absorbance As value and Evans blue seepage discharge (μ
G/mL the linear dependence figure between), the schematic diagram of influence of Fig. 5 particle products to mouse capillary permeability.
As shown in Figure 5, the basic, normal, high dosage group of particle product can reduce mouse capillary permeability, reduce peritoneal fluid
Body oozes out, and has obvious antiinflammatory action, anti-inflammatory effect and model group comparing difference are statistically significant(P<0.01).Particle
Product middle dose group, high dose group and Yinhuang Particle group comparing difference are not statistically significant(P>0.05).In terms of inhibiting rate, particle
The inhibiting rate of product low dose group is worst, but does not have obvious dose-effect relationship between low middle high dose group.(Note:With blank group ratio
Compared with:*P<0.05, * *P<0.01;Compared with Yinhuang Particle group:▲P<0.05, ▲▲P<0.01;Compared with model group:▼P<
0.05, ▼ ▼ P<0.01.)
Fig. 6 is the schematic diagram of influence of the particle product to mouse toes swelling in an embodiment of the invention.
It will be appreciated from fig. 6 that injection carrageenan causes 30min after inflammation, particle product middle dose group, high dose group Carrageenan
Caused normal mouse toes swelling has inhibitory action, and anti-inflammatory effect and model group comparing difference are statistically significant(P<0.01);
2h, 3h after cause is scorching, particle product high dose group and model group comparing difference are statistically significant(P<0.05);24h after cause is scorching,
The grain basic, normal, high dosage group of product and model group comparing difference are not statistically significant(P>0.05), have with blank group comparing difference
Statistical significance(P<0.05 or P<0.01), i.e., the inhibitory action of normal mouse toes swelling caused by particle product Carrageenan
Unobvious.(Note:Compared with blank group:*P<0.05, * *P<0.01;Compared with model group:▲P<0.05, ▲▲P<
0.01.)
Fig. 7 is the schematic diagram of influence of the particle product to mouse swimming time in an embodiment of the invention.
As shown in Figure 7, the basic, normal, high dosage group of particle product can be obviously prolonged mouse swimming power exhaust the death time, resist
Fatigue effect and blank group comparing difference are statistically significant(P<0.01), and be in obvious dose-effect relationship between group, with administration
Dosage increase, antifatigue significant effect enhancing;The anti-fatigue effect of particle product is better than qi and blood recovering capsule group, middle dose group, height
Dosage group and qi and blood recovering capsule group comparing difference are statistically significant(P <0.01).(Note:Compared with physiological saline group:*P<
0.05, * *P<0.01;Compared with qi and blood recovering capsule group:▲P<0.05, ▲▲P<0.01.)
Fig. 8-14 is the schematic diagram in an embodiment of the invention.Wherein, Fig. 8 is particle product to angling on female mice vagina
The schematic diagram of the influence of cell;Fig. 9 is the linear dependence figure between absorbance OD values and progesterone P amounts (ng/mL);Figure 10 is
The schematic diagram of influence of the grain product to female mice progesterone P content;Figure 11 be particle product to female mice body weight, uterus and ovary weight and
The schematic diagram of the influence of organ index;Figure 12 is the schematic diagram of the uterus HE sections of female mice;Figure 13 is the ovary HE sections of female mice
Schematic diagram;Figure 14 is the schematic diagram of influence of the particle product to female mice Follicles sum and corpus luteum number.
Particle product is as follows to the influence result of keratinocyte on female mice vagina:
Through smear microexamination, the regular change of superficial cell quantity and quantity of leucocyte in inverse ratio can be observed in blank group
Change, the cyclically-varying of obvious preoestrus, estrus, metaoestrus and anoestrum is presented.Particle product group and the positive
Control group can be observed occur in blocks or agglomerate superficial cell on vaginal smear within the sampling time, and only a small amount of is white
Cell, showing as vaginal exfoliated sexual cycle extends, is irregular.As shown in Figure 8, bolus for woman diseases group, particle product middle dose group
The estrus of female mice can be extended to some extent with high dose group, positive rate of the superficial cell more than 50% and sky
White group compares, and difference is statistically significant(P <0.05 or P<0.01).Bolus for woman diseases group and particle product high dose group are poor
It is different not statistically significant(P >0.05).(Note:Compared with blank group:*P<0.05, * *P<0.01;Compared with bolus for woman diseases group:▲
P<0.05, ▲▲P<0.01.)
Particle product is as follows to the influence result of female mice progesterone P content:
As shown in Table 10, the basic, normal, high dosage group of particle product can be raised in mice serum to some extent compared with blank group
Progesterone P content;For particle product high dose group compared with blank group, difference is statistically significant(P <0.01).Particle product raises
The effect of progesterone P content is better than bolus for woman diseases group, and for high dose group compared with female red group, difference is statistically significant(P <0.01).
Influence result of the particle product to female mice body weight, weight of reproductive organs and organ index is as follows:
As shown in Figure 11, compared with blank group, the basic, normal, high dosage group body weight of particle product is without significant change, and uterus weight is
Increase, uterus index is slightly larger, but difference is not statistically significant(P>0.05);Particle product high dose group compared with blank group,
Ovary weight substantially increases, and ovarian index significantly increases, and difference is statistically significant(P<0.01).Compared with bolus for woman diseases group,
The equal no significant difference of mouse weight, uterus weight, uterus index of the grain basic, normal, high dosage group of product(P>0.05);Particle product
In, low dose group compared with bolus for woman diseases group, ovary weight is less than normal, and ovarian index is relatively low, and difference is statistically significant(P<0.01);
Particle product high dose group and bolus for woman diseases group ratio, both ovary weights and the equal no significant difference of ovarian index(P>0.05), i.e., it is high
The particle product of dosage can increase the ovary weight and ovarian index of mouse.
Particle product is as follows to the influence result of uterus and ovarian morphology:
From Figure 12, Figure 13, blank group uterine cavity intimal epithelium thinner thickness, lumen of gland is slightly expanded, and blood vessel is less;Ovary body
Product is slightly smaller, and color and luster is pale, and ovarian follicle structure is unclear, or vesica is in reset condition.The ovum of the visible different developmental phases in ovary cortex portion
Bubble, it is seen that a small amount of corpus luteum and lean type are formed, and have no folliculi ovarici vesiculosi, it is seen that appropriate fat drips.Compared with blank group, particle product is low,
Middle and high dosage group uterus outward appearance is thick blue, and inner membrane of uterine cavity epithelium is thickening, lumen of gland expansion, it is seen that vacuole under core, interstitial are loose;
Ovary color and luster is more bright-coloured, and ovarian follicle significantly increases, and ovarian follicle has no obvious cystic dilatation, cytomorphosis, downright bad cell infiltration etc.
Lesion;Medullary substance has no congested, oedema and cell infiltration.More corpus luteum is seen on surface, and the granular cell of corpus luteum physically well develops, form
Completely, marshalling is compacted, and illustrates that ovary has been ovulated.
Particle product is as follows to the influence result of Follicles sum and corpus luteum number in ovary:
As shown in Figure 14, compared with blank group, trend that the ovarian follicle sum of the basic, normal, high dosage group of particle product is significantly increased,
But both no significant differences(P>0.05).Compared with blank, particle product low dose group, the corpus luteum number of middle dose group
It increased, but difference no significant difference(P>0.05), the corpus luteum number of the high agent group of particle product substantially increases, and difference has statistics
Learn meaning(P<0.05).
The present invention in the effect experiment stage, investigated in embodiment 2 particle product to mouse corrosion disease analgesia, it is antifatigue, promote
The influence of Effect of Ovulation, the results showed that the present invention has certain anti-inflammatory and analgesic effect, has significant anti-fatigue effect, one
Determine that progesterone P content can be raised in degree, promote uterus and the development of ovary, keep or strengthen the function of reproductive organs, promote ovarian follicle
Development and ovulation.In a word, can be proved by above-mentioned various experiments, Chinese medicine and health food of the invention, which has, alleviates physical fatigue
Healthcare function, can enriching yin and nourishing kidney, QI invigorating analgesia, keep or enhancing ovarian function.
Finally it should be noted that above content is merely illustrative of the technical solution of the present invention, rather than the present invention is protected
The limitation of scope, the simple modification or equivalent substitution that one of ordinary skill in the art is carried out to technical scheme,
All without departing from the spirit and scope of technical solution of the present invention.
Claims (10)
- A kind of 1. preparation method for being used to alleviate the preparation of physical fatigue, it is characterised in that:It is described to be used to alleviate physical fatigue The preparation method of preparation specifically comprises the following steps:A, raspberry, sealwort, radix polygonati officinalis, spina date seed, matrimony vine and jujube are taken by prescription portion rate, added water to cook 3 times, each 1h, made Obtain extract solution;B, obtained extract solution in above-mentioned steps a is collected, filtration, the extract solution of 3 times is merged, it is dense to concentrate the filtrate to needs Degree, is cooled to room temperature;C, using the extracting method of water extraction and alcohol precipitation method, it is slowly added to ethanol that concentration is 95% and quickly stirs, make containing for extract solution Alcohol amount is 40~70%, and 12h is placed in sealing, centrifuges to obtain supernatant, reclaims ethanol;D, supernatant is collected, through being dried under reduced pressure at a temperature of 60 DEG C to dry cream, plant extracts is made after crushing;E, particle product or powder is made in plant extracts.
- 2. the preparation method according to claim 1 for being used to alleviate the preparation of physical fatigue, it is characterised in that:In preparation Grain product preparation method be:Obtained plant extracts in above-mentioned steps d is taken, adds additives, is mixed, is 80% with concentration Ethanol be made softwood, cross 10 mesh medicines sieve, dried at a temperature of 60 DEG C, whole grain, packing;Medicine sieve used in whole grain is 10 mesh sieves With 65 mesh sieves.
- 3. the preparation method according to claim 1 for being used to alleviate the preparation of physical fatigue, it is characterised in that:Powder in preparation The preparation method of shape product is:Preparation method in step d is changed to collect supernatant, adds additives, constant volume is into needs Volume, filter, dispense, sterilizing.
- 4. the preparation method for being used to alleviate the preparation of physical fatigue according to claim 1,2 or 3, it is characterised in that:Its It is characterised by:Mixed in the step a by the raw material of following parts by weight:1~10 part of raspberry, 1~8 part of sealwort, radix polygonati officinalis 1 0~3 part of~8 parts, 1~6 part of spina date seed, 0~3 part of matrimony vine and jujube.
- 5. the preparation method for being used to alleviate the preparation of physical fatigue according to claim 1,2 or 3, it is characterised in that: In the step a, it is 8~12 times of raw material gross weight to decoct amount of water for the first time, after twice amount of water be the 6 of raw material gross weight ~10 times.
- 6. the preparation method according to claim 5 for being used to alleviate the preparation of physical fatigue, it is characterised in that:In the step In rapid a, decoct that amount of water is raw material gross weight for the first time 12 times, after twice amount of water be 10 times of raw material gross weight.
- 7. the preparation method for being used to alleviate the preparation of physical fatigue according to Claims 2 or 3, it is characterised in that:It is additional Agent is any one or more in the mixture of dietary supplement, filler, preservative, preservative and flavouring to appoint The mixture that meaning ratio mixes, the filler are the auxiliary material for meeting Chinese food laws and regulations requirement.
- 8. the preparation method according to claim 7 for being used to alleviate the preparation of physical fatigue, it is characterised in that:Described meals Food nutritious supplementary pharmaceutical is that mineral matter, vitamin, natto, any one or more in protein powder are mixed with arbitrary proportion Mixture;The mineral matter is that selenium, zinc, calcium, magnesium, potassium, iron, chromium, any one or more in manganese are mixed with arbitrary proportion The mixture formed;The vitamin is beta carotene, vitamin B1, vitamin B6, vitamin C, vitamin D, vitamin E In any one or more mixture mixed with arbitrary proportion;The protein powder is soybean protein isolate, whey Any one or more mixture mixed with arbitrary proportion in albumen, pea protein, collagen.
- 9. the preparation method according to claim 3 for being used to alleviate the preparation of physical fatigue, it is characterised in that:The sterilizing Method uses boiling sterilization, flowing steam sterilization method or autoclaving.
- 10. the preparation method according to claim 1 for being used to alleviate the preparation of physical fatigue, it is characterised in that:In step c The alcohol content for making extract solution is 50%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711114016.5A CN107853703A (en) | 2017-11-13 | 2017-11-13 | A kind of preparation method for being used to alleviate the preparation of physical fatigue |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711114016.5A CN107853703A (en) | 2017-11-13 | 2017-11-13 | A kind of preparation method for being used to alleviate the preparation of physical fatigue |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107853703A true CN107853703A (en) | 2018-03-30 |
Family
ID=61701597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711114016.5A Pending CN107853703A (en) | 2017-11-13 | 2017-11-13 | A kind of preparation method for being used to alleviate the preparation of physical fatigue |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107853703A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105288324A (en) * | 2015-12-10 | 2016-02-03 | 辽宁中医药大学 | Medicine-food formula for constitutions with Yin-deficiency |
CN106074818A (en) * | 2016-08-04 | 2016-11-09 | 广禾堂草本生物科技(上海)有限公司 | There is health food of promotion lactogenic effect and preparation method thereof |
CN106309560A (en) * | 2016-10-10 | 2017-01-11 | 扬中牧乐药业有限公司 | Preparation method of compound mulberry leaf/folium cortex eucommiae granules |
CN106880784A (en) * | 2017-03-23 | 2017-06-23 | 庞会心 | It is a kind of with fatigue-relieving, the Chinese medicine composition of anti-aging and its application |
-
2017
- 2017-11-13 CN CN201711114016.5A patent/CN107853703A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105288324A (en) * | 2015-12-10 | 2016-02-03 | 辽宁中医药大学 | Medicine-food formula for constitutions with Yin-deficiency |
CN106074818A (en) * | 2016-08-04 | 2016-11-09 | 广禾堂草本生物科技(上海)有限公司 | There is health food of promotion lactogenic effect and preparation method thereof |
CN106309560A (en) * | 2016-10-10 | 2017-01-11 | 扬中牧乐药业有限公司 | Preparation method of compound mulberry leaf/folium cortex eucommiae granules |
CN106880784A (en) * | 2017-03-23 | 2017-06-23 | 庞会心 | It is a kind of with fatigue-relieving, the Chinese medicine composition of anti-aging and its application |
Non-Patent Citations (2)
Title |
---|
作者不详: "产后腰酸腰痛的五大元凶,你造么?", 《39健康网》 * |
张宏霞: "抗疲劳药食两用中药现状分析", 《湖南中医药大学学报》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104435775A (en) | Chinese medicinal health-care spirit and preparation method thereof | |
CN102755596B (en) | Traditional Chinese medicine for treating phlegm-dampness hyperplasia of mammary glands and preparation method thereof | |
CN103800670A (en) | Traditional Chinese medicinal preparation for treating kidney-yang deficiency and preparation method thereof | |
CN102058715B (en) | Chinese medicine preparation for treating chronic prostatitis and preparation method thereof | |
CN101607051B (en) | Traditional Chinese medicine composition for losing weight and preparation method thereof | |
CN104208418A (en) | Rosa laevigata michx health oral solution for securing essence, reducing urination and tonifying kidneys and preparation method thereof | |
CN107912773A (en) | A kind of preparation for being used to alleviate physical fatigue | |
CN101507776B (en) | Traditional Chinese medicine preparation for treating kidney deficiency, waist and knees soreness and preparation method thereof | |
CN102988675B (en) | Traditional Chinese medicine combination for treating chronic prostatitis and preparation method thereof | |
CN106721772A (en) | A kind of Chinese medicine composition and its application with fatigue-relieving function | |
CN106579419A (en) | Fatigue alleviating, physical strength restoring and energy replenishing functional food composition | |
CN108066712A (en) | A kind of benefiting qi and nourishing blood Chinese medicine composition | |
CN106237131A (en) | The Herba Taraxaci oral liquor of lowering blood-fat and reducing weight and oral liquid thereof | |
CN106214997A (en) | A kind of Herba Taraxaci oral liquid of Elmination of toxicant and fat-lowering fat-reducing and preparation method thereof | |
CN104888158A (en) | Folium apocyni veneti oral liquid for enhancing immunity and preparation method thereof | |
CN102048913B (en) | Traditional Chinese medicine preparation for treating climacteric syndrome and preparation method thereof | |
CN108633997A (en) | A kind of healthcare goat milk powder and preparation method thereof with anti-fatigue effect | |
CN104043058A (en) | Traditional Chinese medicinal preparation for treating kidney deficiency type lumbar disc herniation and preparation method thereof | |
CN106728130A (en) | A kind of Chinese medicine composition and preparation method and its usage for preventing and treating chronic fatigue syndrome | |
CN103028071A (en) | Traditional Chinese medicine composition for treating diarrhea-dominant irritable bowel syndrome and preparation method of traditional Chinese medicine composition | |
CN102579818A (en) | Traditional Tibetan medicine composition, preparation method thereof and application | |
CN107853703A (en) | A kind of preparation method for being used to alleviate the preparation of physical fatigue | |
CN104740404A (en) | Traditional Chinese medicine composition for treating lupus erythematosus | |
CN104800662A (en) | Traditional Chinese medicine for treating senile heart failure and preparation method thereof | |
CN104800562A (en) | Traditional Chinese medicine composition for treating oral lichen planus and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180330 |